Naxitamab

ATC L01FX21 · 2 markets · 2 records

Naxitamab 2 markets · 2 records Forms

US 1 records · 1 strengths

  • 40 mg/10 mLinjectionDANYELZA

HK 1 records · 1 strengths

    Records without a stated strength · 1 DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.